Wealth Enhancement Advisory Services, LLC Ocugen, Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $61.1 Billion
- Q3 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Ocugen, Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 15,729 shares of OCGN stock, worth $18,717. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,729
Previous 17,083
7.93%
Holding current value
$18,717
Previous $16,000
56.25%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding OCGN
# of Institutions
106Shares Held
60.5MCall Options Held
531KPut Options Held
433K-
Black Rock Inc. New York, NY17.9MShares$21.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.2MShares$18.1 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.16MShares$4.95 Million0.0% of portfolio
-
Gmt Capital Corp Atlanta, GA4.15MShares$4.94 Million0.31% of portfolio
-
Geode Capital Management, LLC Boston, MA3.68MShares$4.38 Million0.0% of portfolio
About Ocugen, Inc.
- Ticker OCGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,566,000
- Market Cap $258M
- Description
- Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...